[JonathanFly]

A quick google search suggests they should be available now. The article specifically talks about the situation your father is in:

https://www.pharmatimes.com/news/nhs_patients_gain_access_to....

>Initially, Ronapreve will be targeted at hospitalised patients who have not mounted an antibody response against COVID-19.

>This includes individuals who are immunocompromised, such as patients with certain cancer or autoimmune diseases.

[deanclatworthy]

Thanks for the reply Jonathan. Sadly just for those who it's probably too late for, and a reactive response rather than pro-active (i.e. to prevent being hospitalised in the first place, given the amount of damage getting to that point can cause to an immunocompromised patient's body in the long term).